Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?

  • Jang, Gwang Cheon (Department of Pediatrics, National Health Insurance Service Ilsan Hospital)
  • Received : 2019.05.15
  • Accepted : 2019.06.22
  • Published : 2019.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309-16. https://doi.org/10.1097/01.all.0000173785.81024.33
  2. Trends in safety information reporting including medicines 2015 [Internet]. Anyang (Korea): Korea Institute of Drug Safety & Risk Management; 2015 [cited 2019 Jun 28]. Available from: https://www.drugsafe.or.kr/iwt/ds/ko/bbs/EgovBbs.do?bbsId=BBSMSTR_000000000021&nttId=1905&pageIndex=1&searchCnd=&searchWrd=.
  3. Jang GC, Lim HS, Lee CJ. Epidemiology of pediatric adverse drug reactions in Korea: using big data of 48.1 million south Korean health-care records and Korea adverse event reporting system database. In:300European Academy of Allergy and Clinical Immunology Congress; 2017 Jun 17-21; Helsinki, Finland.
  4. Chen CB, Hsiao YH, Wu T, Hsih MS, Tassaneeyakul W, Jorns TP, et al. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. Neurology 2017;88:78-86. https://doi.org/10.1212/WNL.0000000000003453
  5. Moon J, Kim TJ, Lim JA, Sunwoo JS, Byun JI, Lee ST, et al. HLA- B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption. Epilepsia 2016;57:1879-86. https://doi.org/10.1111/epi.13566
  6. Verrotti A, Scaparrotta A, Grosso S, Chiarelli F, Coppola G. Anticonvulsant drugs and hematological disease. Neurol Sci 2014;35:983-93. https://doi.org/10.1007/s10072-014-1701-0
  7. Tecoma ES. Oxcarbazepine. Epilepsia 1999;40 Suppl 5:S37-46. https://doi.org/10.1111/j.1528-1157.1999.tb00918.x
  8. Mahmud J, Mathews M, Verma S, Basil B. Oxcarbazepine-induced thrombocytopenia. Psychosomatics 2006;47:73-4. https://doi.org/10.1176/appi.psy.47.1.73
  9. Calamaras MR, Stowe ZN, Newport DJ. Pancytopenia associated with the introduction of oxcarbazepine. J Clin Psychopharmacol 2007;27: 217-8. https://doi.org/10.1097/01.jcp.0000264971.92828.b2
  10. Jung GH, You SJ. Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine. Korean J Pediatr 2019;62: 312-6. https://doi.org/10.3345/kjp.2019.00017